EMA Authorised: Vocabria (cabotegavir sodium;cabotegravir) — ViiV Healthcare B.V.

View source ↗

Summary

EU medicines authority authorised Vocabria (cabotegravir) for HIV infections; marketing authorisation holder is ViiV Healthcare B.V.; decision date 14 August 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• VOCABRIA (cabotegravir sodium)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: ViiV Healthcare B.V.. Decision date: 14/08/2025